The cost of prescription medications has become an increasingly significant issue for many Americans, especially those reliant on Medicare. A recent report by AARP has revealed alarming statistics: the prices for the top 25 drugs covered by Medicare Part D have soared nearly 100% since their market introduction. This finds many elderly and disabled consumers
0 Comments
The landscape of investing continues to evolve, particularly with the emergence of single-stock exchange-traded funds (ETFs). GraniteShares, a pioneer in this domain, launched its first single-stock ETF in 2022 and has since grown its portfolio to an impressive 20 products. Among these is the recently introduced GraniteShares YieldBoost TSLA ETF (TSYY), which is designed specifically
0 Comments
In a noteworthy display of resilience and innovation, Taiwan Semiconductor Manufacturing Company (TSMC) has reported an impressive revenue for the fourth quarter that surpassed analyst forecasts. With revenue reaching 868.5 billion New Taiwan dollars (approximately $26.3 billion), TSMC demonstrated a remarkable year-on-year growth of 38.8%. This achievement not only beat the Refinitiv consensus estimate of
0 Comments
As we usher in 2024, Bitcoin has made headlines by experiencing a staggering price increase of roughly 125% throughout the year, eventually closing near $94,000 after beginning in the low $40,000s. The allure of such significant returns can be irresistible, particularly for new retail investors eager to capitalize on the bullish momentum. Nevertheless, experts advocate
0 Comments
Nordstrom, the renowned Seattle-based department store retailer, surprised analysts and investors alike with an upward revision of its full-year sales outlook, buoyed by unexpectedly robust holiday shopping both in-store and online. Previously, the company had adopted a cautious stance regarding its sales forecasts, attributing this to a noticeable dip in consumer demand as of late
0 Comments